Results 11 to 20 of about 2,254,588 (283)

Expert consensus on the precise classification and diagnosis of acute respiratory distress syndrome [PDF]

open access: yesZhongguo Linchuang Yixue
Acute respiratory distress syndrome (ARDS) is a common critical illness in clinical practice, with a high mortality rate. Given the limited traditional treatment options for ARDS and the high heterogeneity among patients, most clinical trials have failed
Expert Group for Precise Classification and Diagnosis of Acute Respiratory Distress Syndrome
doaj   +2 more sources

Developing Highly Effective Nanoparticle mRNA Therapeutic for Pediatric Acute Respiratory Distress Syndrome. [PDF]

open access: yesAdv Sci (Weinh)
Sepsis‑induced pediatric acute respiratory distress syndrome suppresses FOXF1 in lung endothelial cells which causes life‐threatening lung damage. To counter this, researchers developed nanoparticles that specifically target these cells and deliver FOXF1 mRNA.
Deng Z   +14 more
europepmc   +2 more sources

Acute respiratory distress syndrome

open access: yesEuropean Respiratory Review, 2017
Since its first description, the acute respiratory distress syndrome (ARDS) has been acknowledged to be a major clinical problem in respiratory medicine. From July 2015 to July 2016 almost 300 indexed articles were published on ARDS.
Marco Confalonieri   +2 more
doaj   +7 more sources

Acute respiratory distress syndrome [PDF]

open access: yesClinical Medicine, 2016
Acute respiratory distress syndrome is a common cause of acute respiratory failure that is underdiagnosed both inside and outside of intensive care units. Progression to the most severe forms of the syndrome confers a mortality rate greater than 40% and is associated with often severe functional disability and psychological sequelae in survivors. While
Mason, C, Dooley, N, Griffiths, M
  +13 more sources

Editorial: Respiratory distress syndrome

open access: yesFrontiers in Pediatrics, 2022
Ömer Erdeve   +3 more
doaj   +3 more sources

Síndrome antifosfolipídico catastrófico [PDF]

open access: yes, 2006
[spa] INTRODUCCIÓN: El síndrome antifosfolipídico catastrófico fue descrito por Asherson en el año 1992 como una variante del síndrome antifosfolipídico (SAF) que conduce a insuficiencia multiorgánica, caracteriza por la oclusión trombótica de los vasos ...
Bucciarelli, Silvia
core   +6 more sources

Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants [PDF]

open access: yes, 2023
Background: Premature birth is an important issue in developing and developed countries. The purpose of this study is to investigate the effect of budesonide and surfactant in the treatment of respiratory distress syndrome and the prevention of ...
Norouzi, Elahe   +4 more
core   +1 more source

Acute respiratory distress syndrome [PDF]

open access: yesJournal of Biomedical Science, 2003
Acute respiratory distress syndrome (ARDS) can be associated with various disorders. Among these, coronavirus infection may cause life-threatening severe acute respiratory syndrome (SARS). In this review, we present animal models and techniques for the study of ARDS, and discuss the roles and possible mechanisms of various chemical factors, including ...
Chen, Hsing I.   +4 more
openaire   +2 more sources

Surfactant function in neonates with respiratory distress syndrome [PDF]

open access: yes, 1998
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) who suffered from severe respiratory distress syndrome (RDS) and who had received exogenous bovine lipid extracted surfactant on the first day of life was ...
Griese, Matthias   +3 more
core   +1 more source

Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients [PDF]

open access: yes, 1993
Adult respiratory distress syndrome (ARDS) can develop as a complication of various disorders, including sepsis, but it has not been possible to identify which of the patients at risk will develop this serious disorder.
Moore, Frederick A.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy